Free Trial

488,178 Shares in Concentrix Co. (NASDAQ:CNXC) Purchased by Alyeska Investment Group L.P.

Concentrix logo with Business Services background

Alyeska Investment Group L.P. acquired a new position in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 488,178 shares of the company's stock, valued at approximately $21,123,000. Alyeska Investment Group L.P. owned about 0.76% of Concentrix as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Barclays PLC boosted its stake in Concentrix by 134.3% in the 3rd quarter. Barclays PLC now owns 35,862 shares of the company's stock worth $1,837,000 after buying an additional 20,559 shares during the last quarter. Nordea Investment Management AB increased its position in Concentrix by 43.9% during the fourth quarter. Nordea Investment Management AB now owns 70,654 shares of the company's stock worth $3,076,000 after purchasing an additional 21,568 shares during the last quarter. First Hawaiian Bank increased its position in Concentrix by 51.3% during the fourth quarter. First Hawaiian Bank now owns 13,619 shares of the company's stock worth $589,000 after purchasing an additional 4,619 shares during the last quarter. Harbor Capital Advisors Inc. raised its stake in Concentrix by 46.6% during the fourth quarter. Harbor Capital Advisors Inc. now owns 31,756 shares of the company's stock worth $1,374,000 after purchasing an additional 10,089 shares during the period. Finally, Impact Partnership Wealth LLC acquired a new position in shares of Concentrix in the 4th quarter valued at $323,000. Hedge funds and other institutional investors own 90.34% of the company's stock.

Insider Buying and Selling at Concentrix

In other news, EVP Cormac J. Twomey sold 500 shares of the firm's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $55.31, for a total value of $27,655.00. Following the transaction, the executive vice president now directly owns 39,130 shares in the company, valued at approximately $2,164,280.30. This trade represents a 1.26 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Olivier Duha sold 29,444 shares of the business's stock in a transaction dated Tuesday, April 15th. The shares were sold at an average price of $48.52, for a total transaction of $1,428,622.88. Following the sale, the director now directly owns 1,155,862 shares of the company's stock, valued at approximately $56,082,424.24. This represents a 2.48 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,444 shares of company stock worth $1,481,628 over the last quarter. 3.20% of the stock is owned by corporate insiders.

Concentrix Stock Up 2.5 %

NASDAQ CNXC traded up $1.30 during mid-day trading on Friday, reaching $53.33. 593,683 shares of the company's stock traded hands, compared to its average volume of 703,079. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 1.17. Concentrix Co. has a 1-year low of $36.28 and a 1-year high of $77.00. The company has a fifty day simple moving average of $48.79 and a 200-day simple moving average of $46.48. The company has a market cap of $3.41 billion, a price-to-earnings ratio of 14.37, a P/E/G ratio of 0.63 and a beta of 0.52.

Concentrix (NASDAQ:CNXC - Get Free Report) last released its quarterly earnings results on Wednesday, March 26th. The company reported $2.79 earnings per share for the quarter, topping analysts' consensus estimates of $2.58 by $0.21. The business had revenue of $2.37 billion during the quarter, compared to the consensus estimate of $2.37 billion. Concentrix had a net margin of 2.61% and a return on equity of 16.67%. The business's quarterly revenue was down 1.3% compared to the same quarter last year. During the same quarter last year, the company earned $2.57 earnings per share. As a group, equities research analysts expect that Concentrix Co. will post 10.11 EPS for the current year.

Concentrix Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 6th. Investors of record on Friday, April 25th were issued a $0.3328 dividend. This represents a $1.33 annualized dividend and a yield of 2.50%. The ex-dividend date was Friday, April 25th. Concentrix's dividend payout ratio is currently 33.33%.

Analysts Set New Price Targets

Several research analysts recently weighed in on CNXC shares. Bank of America increased their target price on Concentrix from $58.00 to $59.00 and gave the stock a "neutral" rating in a research report on Thursday, March 27th. Barrington Research reduced their price objective on Concentrix from $70.00 to $54.00 and set an "outperform" rating on the stock in a research note on Monday, March 24th. Finally, Canaccord Genuity Group decreased their target price on Concentrix from $100.00 to $80.00 and set a "buy" rating for the company in a report on Thursday, January 16th. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $65.75.

View Our Latest Stock Analysis on Concentrix

About Concentrix

(Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Recommended Stories

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Should You Invest $1,000 in Concentrix Right Now?

Before you consider Concentrix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.

While Concentrix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines